Literature DB >> 2405697

Use of a variable tracer infusion method to determine glucose turnover in humans.

J M Molina1, A D Baron, S V Edelman, G Brechtel, P Wallace, J M Olefsky.   

Abstract

The single-compartment pool fraction model, when used with the hyperinsulinemic glucose clamp technique to measure rates of glucose turnover, sometimes underestimates true rates of glucose appearance (Ra) resulting in negative values for hepatic glucose output (HGO). We focused our attention on isotope discrimination and model error as possible explanations for this underestimation. We found no difference in [3-3H] glucose specific activity in samples obtained simultaneously from the femoral artery and vein (2,400 +/- 455 vs. 2,454 +/- 522 dpm/mg) in 6 men during a hyperinsulinemic euglycemic clamp study where insulin was infused at 40 mU.m-2.min-1 for 3 h; therefore, isotope discrimination did not occur. We compared the ability of a constant (0.6 microCi/min) vs. variable tracer infusion method (tracer added to the glucose infusate) to measure non-steady-state Ra during hyperinsulinemic clamp studies. Plasma specific activity fell during the constant tracer infusion studies but did not change from base line during the variable tracer infusion studies. By maintaining a constant plasma specific activity the variable tracer infusion method eliminates uncertainty about changes in glucose pool size. This overcame modeling error and more accurately measures non-steady-state Ra (P less than 0.001 by analysis of variance vs. constant infusion method). In conclusion, underestimation of Ra determined isotopically during hyperinsulinemic clamp studies is largely due to modeling error that can be overcome by use of the variable tracer infusion method. This method allows more accurate determination of Ra and HGO under non-steady-state conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405697     DOI: 10.1152/ajpendo.1990.258.1.E16

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy.

Authors:  C Hadigan; D Kamin; J Liebau; S Mazza; S Barrow; M Torriani; R Rubin; S Weise; A Fischman; S Grinspoon
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-08-30       Impact factor: 4.310

3.  A noninvasive method to measure splanchnic glucose uptake after oral glucose administration.

Authors:  B Ludvik; J J Nolan; A Roberts; J Baloga; M Joyce; J M Bell; J M Olefsky
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

4.  Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus.

Authors:  B Ludvik; J J Nolan; A Roberts; J Baloga; M Joyce; J M Bell; J M Olefsky
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Authors:  A Vaag; F Alford; F L Henriksen; M Christopher; H Beck-Nielsen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.

Authors:  R Laager; R Ninnis; U Keller
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Mechanisms of fatty acid-induced inhibition of glucose uptake.

Authors:  G Boden; X Chen; J Ruiz; J V White; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Effects of fat on insulin-stimulated carbohydrate metabolism in normal men.

Authors:  G Boden; F Jadali; J White; Y Liang; M Mozzoli; X Chen; E Coleman; C Smith
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.

Authors:  A S Petrides; L C Groop; C A Riely; R A DeFronzo
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

10.  Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.

Authors:  G Boden; X Chen
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.